| Record ID | marc_loc_2016/BooksAll.2016.part28.utf8:228142419:1455 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part28.utf8:228142419:1455?format=raw |
LEADER: 01455cam a22003974a 4500
001 2001051561
003 DLC
005 20080312083924.0
008 011002s2002 njua b 001 0 eng
010 $a 2001051561
020 $a0896039382 (alk. paper)
035 $a(DNLM)101129213
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aRC268.42$b.T37 2002
060 10 $aQZ 267$bT185 2002
082 00 $a616.99/4061$221
245 00 $aTargets for cancer chemotherapy :$btranscription factors and other nuclear proteins /$cedited by Nicholas B. La Thangue and Lasantha R. Bandara.
260 $aTotowa, N.J. :$bHumana Press,$cc2002.
300 $axii, 352 p. :$bill. ;$c24 cm.
440 0 $aCancer drug discovery and development
504 $aIncludes bibliographical references and index.
650 0 $aOncogenes.
650 0 $aTumor proteins.
650 0 $aTranscription factors.
650 0 $aCancer$xChemotherapy.
650 12 $aNeoplasms$xdrug therapy.
650 22 $aDrug Design.
650 22 $aGenes, Suppressor, Tumor$xphysiology.
650 22 $aOncogene Proteins.
650 22 $aReceptors, Cytoplasmic and Nuclear.
650 22 $aTranscription Factors.
700 1 $aLa Thangue, Nicholas B.
700 1 $aBandara, Lasantha R.
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0825/2001051561-d.html
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/enhancements/fy0825/2001051561-t.html